Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neurofibroma, Plexiform × Pharmacokinetics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 2 Pancreatic Neoplasms 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, B-Cell 1 Lymphoma 1 Hodgkin Disease 1

Interventions

AZD 6244 2 pirfenidone 1 cabozantinib 1 Sorafenib 1 Pharmacokinetics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00727233 2019-12-12

Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon ⚡